Plain-English translation of NCT02037867 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking for the best ways to spot early liver damage in people who are at higher risk—such as those who drink heavily, have type 2 diabetes, or struggle with obesity. Researchers will collect a blood sample from you and perform a non-invasive ultrasound scan called a FibroScan to measure how much scarring, if any, your liver may have. The goal is to understand whether these simple blood tests and scans can help catch liver problems before they become serious, so doctors can help you sooner.
Liver disease often develops silently without symptoms, and by the time it's detected, serious damage may have already happened. This study exists to see whether newer blood tests and simple scans can identify people with early liver damage while there's still time to make a difference through lifestyle changes or other treatments.
You likely qualify if…
You likely don't qualify if…
You will have a one-time blood draw and a painless ultrasound scan of your liver called a FibroScan (which takes about 5–10 minutes). After that, researchers will keep in touch with you over many years using your medical records to track whether you develop liver or heart problems. Your regular doctor visits and usual care will continue as normal, and you won't need to attend any special study appointments unless you choose to be interviewed about lifestyle changes.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United Kingdom